Enrolling study

Living With COPD? Research Study for Adults 40–80

We're studying an investigational study drug, given as an injection, to see if it can possibly help adults with moderate to severe COPD breathe easier.

COPD (Chronic Obstructive Pulmonary Disease)

Medically reviewed and certified by

Study information reviewed by our licensed physician investigators.

About this study

Some participants will receive the investigational study drug, while others will receive a placebo (a non-active substance); everyone is monitored closely by our team of doctors and nurses. The study drug or placebo could be given on a regular schedule, such as once every few weeks, with check-ups at the study clinic. Participation is voluntary and you may leave the study at any time.

Condition: COPD (Chronic Obstructive Pulmonary Disease)
Age range: 40–80
Estimated duration: Several months, with visits spread throughout
Study visits: 12

Eligibility snapshot

Age 40–80 years old
Moderate to severe COPD for at least 1 year
Current or former smoker with a history of smoking
Do not have asthma
No major surgery in the past 8 weeks
No serious health problems that might affect participation (such as active cancer)

What to expect

1Screening: our team will check if you meet the study requirements and discuss your health
2Study treatment: you'll receive the investigational study drug or placebo on a regular schedule and attend check-ups
3Follow-up: once the study treatment ends, we'll have a final check to see how you're doing
4Total time: participation could last several months, with visits spread out throughout
5Reimbursement: we may cover some costs of participation or provide financial support for travel

What kind of study tests can I expect?

At study visits, there will be health checks and tests to monitor your health and for research purposes. The number of tasks varies per visit.

Blood tests
Breathing tests
Electrocardiograms (ECGs)
Vital signs monitoring
Physical exams
Pulmonary function tests (PFTs)
Symptom questionnaires

Benefits & risks

Potential benefits

You may potentially experience improvement in symptoms, though this isn't guaranteed.
Receive study-related medical care from our study team.

Potential risks

There may be side effects or discomfort from the study procedures.
You may not experience improvement, and you could receive a placebo.

Compensation

Compensation for time and travel may be available.

View study details

Location & Principal Investigator

45 Alabama Rd N. Unit 8, Lehigh Acres, FL 33936

Studies at this site are conducted by our Principal Investigators and research staff.

Meet the research team

Frequently asked questions

Answers to questions we hear most often.

What does participation involve?

Participation involves scheduled study visits with assessments defined by the protocol. Everything that will be asked of you is described in the informed consent document before you decide.

How long is the study?

The estimated duration is listed above. Your coordinator will review the full visit schedule with you during the consent process.

Will I be compensated for time and travel?

Where compensation is offered, the amount and payment schedule are described in the informed consent document and reviewed with you before enrollment.

What are the eligibility requirements?

The listing above shows a high-level snapshot. Full criteria are defined in the protocol and confirmed by the study team at a screening visit.

Can I leave the study at any time?

Yes. Participation is voluntary and you may withdraw at any time. Your coordinator will discuss any recommended safety follow-up.

Is my information kept confidential?

Yes. Access is limited to delegated study staff, and information shared with the sponsor is coded wherever the protocol allows.

Think you may qualify?

This study is conducted under IRB oversight in accordance with Good Clinical Practice guidelines. Eligibility is confirmed by the study team; the information here is a summary and not a full protocol. Additional eligibility criteria will be assessed by the study doctor or staff during the screening process prior to being enrolled in the study and receiving any investigational medication. Not all individuals will qualify to participate. The investigational study drug is not approved by health authorities such as the US Food and Drug Administration (FDA) and is still under investigation for the treatment of COPD, so its effectiveness and safety have not been established.